Oppenheimer & Co. Inc. Strengthens Equities and Biotech Research Teams with Addition of Kostas Biliouris, Ph.D.
Oppenheimer Holdings, Inc. Class A (DE) (OPY)
US:NYSE Investor Relations:
opco.com/investor-relations/index.aspx
Company Research
Source: PR Newswire
The addition of well-respected biotech expert strengthens one of Oppenheimer's longest-standing franchise areasNEW YORK, Dec. 8, 2025 /PRNewswire/ -- Oppenheimer & Co. Inc., a leading investment bank, wealth manager and subsidiary of Oppenheimer Holdings (NYSE: OPY), today announced that Kostas Biliouris has joined the firm as Managing Director on its Biotech Research Team. He will report to William (Bill) Bird, Director of Research, and be based in New York City.Biliouris comes to Oppenheimer from BMO Capital Markets, where he was a Director, mainly covering the genetic medicines space. Before BMO, he was a VP in Biotech Research at Morgan Stanley and worked in drug development and product strategy at Novartis. His background includes a Ph.D. in biochemical engineering and his scientific work was published in collaboration with Biogen, Ionis, Merck, Novartis, and the FDA."Kostas brings a rare combination of scientific depth, industry experience, and securities analysis that fits dire
Show less
Read more
Impact Snapshot
Event Time:
OPY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OPY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OPY alerts
High impacting Oppenheimer Holdings, Inc. Class A (DE) news events
Weekly update
A roundup of the hottest topics
OPY
News
- Oppenheimer Holdings declares $1.00 special dividend [Seeking Alpha]Seeking Alpha
- OPPENHEIMER HOLDINGS INC. DECLARES SPECIAL DIVIDENDPR Newswire
- Oppenheimer Holdings Inc. (NYSE:OPY) has caught the attention of institutional investors who hold a sizeable 39% stake [Yahoo! Finance]Yahoo! Finance
- Oppenheimer & Co. Inc. Appoints Keith Peterson As Head of Cash Equity Sales and Trading [Yahoo! Finance]Yahoo! Finance
- Oppenheimer & Co. Inc. Appoints Keith Peterson As Head of Cash Equity Sales and TradingPR Newswire
OPY
Sec Filings
- 12/12/25 - Form 8-K
- 12/5/25 - Form 40-APP
- 11/3/25 - Form 8-K
- OPY's page on the SEC website